Douglas W. McMillin

Targeting transcription regulation in cancer with a covalent CDK7 inhibitor

Nicholas Kwiatkowski, Tinghu Zhang, Peter B. Rahl et al. · Nature · 2014 · 900 citations · Full text

Medicine, Cancer Biology, Molecular Biology +12

Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity

Douglas W. McMillin, Jake Delmore, Ellen Weisberg et al. · Nature Medicine · 2010 · 315 citations · Full text

Medicine, Cancer Biology, Oncology +16

VLA-5 is expressed by mouse and human long-term repopulating hematopoietic cells and mediates adhesion to extracellular matrix protein fibronectin.

Jocelyn Loo, Xiang Xiao, Douglas W. McMillin et al. · Journal of Clinical Investigation · 1998 · 162 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia

Xavier Leleu, Xiaoying Jia, Judith Runnels et al. · Blood · 2007 · 141 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +11

Antitumor Effects of the Proteasome Inhibitor Bortezomib in Medullary and Anaplastic Thyroid Carcinoma Cells in Vitro

Constantine S. Mitsiades, Douglas W. McMillin, Vassiliki Kotoula et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 127 citations · Full text

Medicine, Oncology, Pharmacology +15